We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Heparin Assay Is Fully Automated on Hemostasis Testing Systems

By LabMedica International staff writers
Posted on 20 Aug 2009
A ready-to-use, universal heparin assay determines unfractionated heparin (UFH) and low-molecular weight heparin (LMWH) activity in human citrated plasma.

UFH and LMWH are widely used anticoagulants, administered for the prophylaxis and treatment of a number of cardiovascular disorders, including venous thromboembolism, unstable angina, and acute myocardial infarction.

The HemosIL liquid heparin assay is a liquid, ready-to-use, assay universal heparin assay for the quantitative determination of unfractionated heparin (UFH) and low-molecular weight heparin (LMWH) activity in human citratedplasma. Fully automated on IL Hemostasis testing systems, it is a one-stage chromogenic assay, with excellent correlation with traditional two-stage assays, providing greater simplicity and efficiency. This allows customers to move testing to the routine lab from the specialty lab, ensuring availability 24 hours/day, 7 days/week. The assay can be performed on the ACL TOP Family, ACL Elite/Elite Pro/8/9/10000, and ACL Futura/ACL Advance.

The U.S. Food and Drug Administration (Silver Spring, MD, USA) has granted Instrumentation Laboratory Company Inc. (IL; Lexington, MA, USA) 510(k) clearance for the HemosIL liquid heparin assay. Previously, the company received a license for the product from Health Canada, as well as a European CE in vitro diagnostics (IVD) mark. With the US clearance, the company will initiate commercialization of the HemosIL assay in North America and European countries. IL will coordinate commercialization of the product in North America, with its distribution partner, Beckman Coulter Inc. (Fullerton, CA, USA).

Instrumentation Laboratory Company, Inc. develops, manufactures, and distributes in vitro diagnostic instruments, reagents, supplies, and controls for hospitals and independent clinical laboratories. The company offers blood testing, microcoagulation, quality control, and coagulation analyzer systems, as well as a Windows application that consolidates data.

Related Links:
U.S. Food and Drug Administration
Instrumentation Laboratory Company Inc.
Beckman Coulter Inc.




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T

Latest Clinical Chem. News

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
20 Aug 2009  |   Clinical Chem.

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
20 Aug 2009  |   Clinical Chem.

Low-Cost Portable Screening Test to Transform Kidney Disease Detection
20 Aug 2009  |   Clinical Chem.